Delivery Order SPE2DR25D2104-SPE2DR26F3QUU
- Not listed
- The Defense Logistics Agency awarded a $3,336.89 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Linzess 145 microgram capsules (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of December 3, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $9,813.51 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Linzess 145 mcg capsules (30-count units). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,014.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Linzess 145 micrograms capsules (30-count units). This non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a $2,355.01 delivery order to AmerisourceBergen Drug Corp for Linzess 145 mcg capsules (30-count units) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work is performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,335.78 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Linzess 290 microgram capsules in quantities of 30 units. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement with a completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Linzess 145 microgram capsules (30-count units) valued at $9,140.32. This is a firm fixed-price, competitive delivery order with no set-aside designation and an ultimate completion date of September 15, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a $4,841.41 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Linzess 72 mcg capsules (30-count unit of use packaging). This is a firm fixed price, non-set-aside contract with a completion date of December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a discrete delivery order under AmerisourceBergen's larger relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.46 to AmerisourceBergen Drug Corp for the supply of Linzess 72 milligram capsules (30-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,678.18 delivery order to AmerisourceBergen Drug Corp for LINZESS 145 microgram capsules (30-count units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the awardee's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,349.27 to AmerisourceBergen Drug Corp for the supply of Linzess 145 microgram capsules (30-count units) with an ultimate completion date of July 31, 2025. This competitive award, issued on July 30, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QUUDelivery Order
The Defense Logistics Agency awarded a $1,711.90 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Linzess 145 microgram capsules (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive SPE2DX vehicle to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a major healthcare solutions provider headquartered in Pennsylvania, the company demonstrates established capability in fulfilling federal medical procurement requirements through open competition, consistently receiving delivery orders at varying scales to support Defense Health Agency, U.S. Coast Guard, and other government healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/7/25 |